World Top 100 Biotechnology Companies List by Market Cap in January 2024

World Top 100 Biotechnology Companies List by Market Cap in January 2024, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as pf Jan-05-2024.

World Top Biotechnology Companies in 2024
World Largest Biotechnology Companies by Market Cap in 2024, World Top Biotechnology Companies by Market Cap in 2024.

  1. Relay Therapeutics Inc.

    World Rank (Jan-05-2024)
    6,953
    Market Cap (Jan-05-2024)
    1.434 Billion USD
    World Rank (Jul-30-2023)
    6,911
    Market Cap (Jul-30-2023)
    1.487 Billion USD
    World Rank (Dec-25-2022)
    5,890
    Market Cap (Dec-25-2022)
    1.765 Billion USD
    World Rank (Jan-07-2022)
    4,967
    Market Cap (Jan-07-2022)
    2.90 Billion USD
    Annual Revenue in USD
    1 Million USD
    Annual Operating Income in USD
    -310 Million USD
    Annual Net Income in USD
    -290 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Relay Therapeutics is a Biotechnology company related to Clinical Stage Precision Medicine company focused on transforming the drug discovery process. The company estimated annual revenue is currently 22 million per year and 122 employees as on 2019. The headquarters is in USA.
    Company Website
    RELAY THERAPEUTICS, INC.

  2. Ardelyx

    World Rank (Jan-05-2024)
    6,971
    Market Cap (Jan-05-2024)
    1.428 Billion USD
    World Rank (Jul-30-2023)
    9,735
    Market Cap (Jul-30-2023)
    0.828 Billion USD
    World Rank (Dec-25-2022)
    13,070
    Market Cap (Dec-25-2022)
    0.452 Billion USD
    World Rank (Jan-07-2022)
    22,233
    Market Cap (Jan-07-2022)
    0.11 Billion USD
    Annual Revenue in USD
    52 Million USD
    Annual Operating Income in USD
    -64 Million USD
    Annual Net Income in USD
    -67 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile

    Ardelyx is a Biotechnology company enabled to develop a pipeline of drug candidates designed to better manage complications related to kidney and cardiorenal diseases. The headquarters is in USA.

    Facts About Company

    Ardelyx Annual Total Revenue for year ending Dec-2022 was 52 million USD and and Net loss for year ending Dec-2022 was -67 million USD.

    Ardelyx Annual Total Revenue for year ending Dec-2021 was 10 million USD and and Net loss for year ending Dec-2021 was -158 million USD.

    As on 2022, Ardelyx has 133 employees.

    Company Website
    ARDELYX

  3. MorphoSys AG

    World Rank (Jan-05-2024)
    7,047
    Market Cap (Jan-05-2024)
    1.408 Billion USD
    World Rank (Jul-30-2023)
    8,649
    Market Cap (Jul-30-2023)
    1.017 Billion USD
    World Rank (Dec-25-2022)
    13,250
    Market Cap (Dec-25-2022)
    0.439 Billion USD
    World Rank (Jan-07-2022)
    8,572
    Market Cap (Jan-07-2022)
    1.18 Billion USD
    Annual Revenue in USD
    307 Million USD
    Annual Operating Income in USD
    -243 Million USD
    Annual Net Income in USD
    -166 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Germany
    Yahoo @ Frankfurt
    Company Profile
    MORPHOSYS AG is Biotechnology sector company with headquarters is in Germany.
    Company Website
    MORPHOSYS AG
    Wikipedia
    Wikipedia

  4. Chengdu Kanghua Biological Products Co. Ltd

    World Rank (Jan-05-2024)
    7,057
    Market Cap (Jan-05-2024)
    1.406 Billion USD
    World Rank (Jul-30-2023)
    8,049
    Market Cap (Jul-30-2023)
    1.148 Billion USD
    World Rank (Dec-25-2022)
    6,303
    Market Cap (Dec-25-2022)
    1.596 Billion USD
    World Rank (Jan-07-2022)
    4,447
    Market Cap (Jan-07-2022)
    3.39 Billion USD
    Annual Revenue in USD
    190 Million USD
    Annual Net Income in USD
    122 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    China
    Company Website
    CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO., LTD.

  5. Kiniksa Pharmaceuticals

    World Rank (Jan-05-2024)
    7,059
    Market Cap (Jan-05-2024)
    1.405 Billion USD
    World Rank (Jul-30-2023)
    7,387
    Market Cap (Jul-30-2023)
    1.325 Billion USD
    World Rank (Dec-25-2022)
    8,029
    Market Cap (Dec-25-2022)
    1.075 Billion USD
    World Rank (Jan-07-2022)
    10,948
    Market Cap (Jan-07-2022)
    0.76 Billion USD
    Annual Revenue in USD
    38 Million USD
    Annual Net Income in USD
    -157 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Bermuda
    Yahoo @ Nasdaq
    Company Website
    KINIKSA PHARMACEUTICALS

  6. Mirum Pharmaceuticals

    World Rank (Jan-05-2024)
    7,121
    Market Cap (Jan-05-2024)
    1.384 Billion USD
    World Rank (Jul-30-2023)
    8,800
    Market Cap (Jul-30-2023)
    0.988 Billion USD
    World Rank (Dec-25-2022)
    10,559
    Market Cap (Dec-25-2022)
    0.673 Billion USD
    World Rank (Jan-07-2022)
    13,731
    Market Cap (Jan-07-2022)
    0.48 Billion USD
    Annual Revenue in USD
    77 Million USD
    Annual Operating Income in USD
    -131 Million USD
    Annual Net Income in USD
    -135 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Mirum Pharmaceuticals is a Clinical Stage Biopharmaceutical company focused on clinical studies for the treatment of cholestatic diseases including primary sclerosing cholangitis (PSC), intrahepatic cholestasis of pregnancy (ICP) and primary biliary cholangitis (PBC). It is having 24 employees as on 2019. The headquarters is in USA.
    Company Website
    MIRUM PHARMACEUTICALS

  7. Vir Biotechnology

    World Rank (Jan-05-2024)
    7,125
    Market Cap (Jan-05-2024)
    1.382 Billion USD
    World Rank (Jul-30-2023)
    5,935
    Market Cap (Jul-30-2023)
    1.894 Billion USD
    World Rank (Dec-25-2022)
    3,703
    Market Cap (Dec-25-2022)
    3.425 Billion USD
    World Rank (Jan-07-2022)
    3,617
    Market Cap (Jan-07-2022)
    4.40 Billion USD
    Annual Revenue in USD
    1,580 Million USD
    Annual Operating Income in USD
    833 Million USD
    Annual Net Income in USD
    515 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Vir Biotechnology is a Clinical Stage Immunology company. It is focused on combining immunologic insights with cutting edge technologies to treat and prevent serious infectious diseases. The headquarters is in USA.

    Company Website
    VIR BIOTECHNOLOGY

  8. Morphic Holding

    World Rank (Jan-05-2024)
    7,160
    Market Cap (Jan-05-2024)
    1.369 Billion USD
    World Rank (Jul-30-2023)
    4,888
    Market Cap (Jul-30-2023)
    2.536 Billion USD
    World Rank (Dec-25-2022)
    8,376
    Market Cap (Dec-25-2022)
    0.995 Billion USD
    World Rank (Jan-07-2022)
    6,756
    Market Cap (Jan-07-2022)
    1.77 Billion USD
    Annual Revenue in USD
    71 Million USD
    Annual Operating Income in USD
    -63 Million USD
    Annual Net Income in USD
    -59 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile
    Morphic Holding is a Biopharmaceutical company leading the development of a new generation of oral integrin drugs and a unique integrin discovery platform. It is having 76 employees as on 2019. The headquarters is in USA.
    Company Website
    MORPHIC HOLDING

  9. Xencor

    World Rank (Jan-05-2024)
    7,236
    Market Cap (Jan-05-2024)
    1.346 Billion USD
    World Rank (Jul-30-2023)
    7,028
    Market Cap (Jul-30-2023)
    1.449 Billion USD
    World Rank (Dec-25-2022)
    6,390
    Market Cap (Dec-25-2022)
    1.564 Billion USD
    World Rank (Jan-07-2022)
    5,875
    Market Cap (Jan-07-2022)
    2.22 Billion USD
    Annual Revenue in USD
    164 Million USD
    Annual Operating Income in USD
    -82 Million USD
    Annual Net Income in USD
    -55 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Xencor is a Clinical Stage Biopharmaceutical company. It has portfolio of 18 proprietary and partnered therapeutic antibody and cytokine programs in clinical development for the treatment of cancer autoimmune disorders and infectious disease. The headquarters is in USA.
    Facts About Company
    As on 2021, Xencor had 254 full-time employees.
    Company Website
    XENCOR INC

  10. Agios Pharmaceuticals

    World Rank (Jan-05-2024)
    7,260
    Market Cap (Jan-05-2024)
    1.340 Billion USD
    World Rank (Jul-30-2023)
    6,950
    Market Cap (Jul-30-2023)
    1.477 Billion USD
    World Rank (Dec-25-2022)
    6,594
    Market Cap (Dec-25-2022)
    1.485 Billion USD
    World Rank (Jan-07-2022)
    6,755
    Market Cap (Jan-07-2022)
    1.77 Billion USD
    Annual Revenue in USD
    14 Million USD
    Annual Operating Income in USD
    -389 Million USD
    Annual Net Income in USD
    -231 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Bio-pharmaceutical company with headquarters is in Massachusetts, USA.
    Company Website
    AGIOS PHARMACEUTICALS INC

Share